MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0145635
Vqure Pharmaceuticals Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹86.82 Lakh
▼ 36% YoY
Net loss · FY 2023
₹10.57 Lakh
Net margin -12.2%
EBITDA · FY 2023
-₹10.56 Lakh
EBITDA margin -12.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
GST registrations
1
None active
About Vqure Pharmaceuticals Private Limited
Data last updated:
Vqure Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 November 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2016PTC288054. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shivakant Mishra and Virendra Dayashankar Mishra.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Shop No. 117 1st Floor Reliable Prestige – 1 Achole Road Nalasopara East, Thane, Maharashtra, India – 401209.
As per the financials filed for FY 2023, the company reported a revenue of ₹86.82 Lakh, a decline of 36% compared to the previous year. For the same year it recorded a net loss of ₹10.57 Lakh (net margin -12.2%) and EBITDA of -₹10.56 Lakh (EBITDA margin -12.2%). Revenue has declined at a compounded annual rate (CAGR) of 29% over three years and 15% over five years.
Court records list 10 cases involving the company, including 10 filed against it; 4 cases are pending.
Vqure Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0145635). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vqurepharma.com.
Company details
CIN U51909MH2016PTC288054
Registration Number 288054
Incorporation Date 30 November 2016
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0145635
Recognitions & Rankings of Vqure Pharmaceuticals
Contact details
Vqure Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its website is vqurepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShop No. 117 1st Floor Reliable Prestige – 1 Achole Road Nalasopara East, Thane, Maharashtra, India – 401209
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Vqure Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Vqure Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Vqure Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Vqure Pharmaceuticals Private Limited, buy the company report.
Financials of Vqure Pharmaceuticals Private Limited
FY 2023 filings availableVqure Pharmaceuticals Private Limited reported revenue of ₹86.82 Lakh (down 36% YoY) for FY 2023.
Revenue · FY 2023
₹86.82 Lakh ▼ 36%
Net loss · FY 2023
₹10.57 Lakh margin -12.2%
EBITDA · FY 2023
-₹10.56 Lakh margin -12.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 36%
3 years · compounded
▲ 29%
5 years · compounded
▼ 15%
EBITDA CAGR growth
1 year
▼ 642%
3 years · compounded
▼ 148%
5 years · compounded
▼ 46%
Revenue has declined at a compounded annual rate (CAGR) of 15% over five years, including a 36% fall in the latest year. EBITDA fell 642% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹86.82 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹10.56 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹10.57 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -12.2% | ||||
| Net Profit Margin | -12.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vqure Pharmaceuticals Private Limited, buy the company report.
Board of directors of Vqure Pharmaceuticals Private Limited
Vqure Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivakant Mishra | Director | 01 Aug 2018 | 8 Years 2 Months | Current |
| Virendra Dayashankar Mishra Also directs: G Smart Infra LLP | Director | 30 Nov 2016 | 9 Years 10 Months | Current |
Peer comparison
Vqure Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nishant Distributors Private Limited | ₹87.06 Lakh (FY 2025) | -26.0% | Ranchi, Jharkhand, India | |||
| SVS Intermediates Private Limited | ₹87.05 Lakh (FY 2022) | -29.0% | Singavaram, Telangana, India | |||
| Vqure Pharmaceuticals Private Limitedthis company | ₹86.82 Lakh (FY 2023) | -₹10.57 Lakh | -12.2% | -36.0% | Thane, Maharashtra, India | |
| Jonas Pharmaceuticals Private Limited | ₹86.77 Lakh (FY 2025) | 12.0% | Ambala, Haryana, India | |||
| Elemensis Lifesciences Private Limited | ₹86.75 Lakh (FY 2025) | 373.0% | Delhi, India | |||
| Tenfold Pharmaceuticals Private Limited | ₹86.68 Lakh (FY 2025) | -19.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Vqure Pharmaceuticals Private Limited, buy the company report.
Auditor
Vqure Pharmaceuticals Private Limited is audited by Rakesh Mishra & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rakesh Mishra & Associates | FY 2023 | 144715 |
Shareholding
The shareholding of Vqure Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vqure Pharmaceuticals Private Limited, buy the company report.
Legal cases
Vqure Pharmaceuticals Private Limited has 10 court cases on record: 10 filed against it. 4 cases are pending and 6 are disposed.
Total cases
10
Filed against the company
10
Pending
4
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 10 | 4 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by L and T Finance Ltd .. | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Ugro Capital Limited | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Interim or miscellaneous application | Filed against the company by Idfc First Bank Limited Through Its Authorized Officer Mr Jitesh Sawant and 1 other | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Cholamandalam Investment and Finance Company Ltd | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Cholamandalam Investment and Finance Co Ltd | Disposed |
To see the full case history of Vqure Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vqure Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vqure Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
To see the full GST registrations and return filing status of Vqure Pharmaceuticals Private Limited, buy the company report.
Recent activity
Vqure Pharmaceuticals Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Sirisha Jagadish Kumar Vaddi ceased to be Director on 24 Dec 2021.
AGM
Vqure Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Vqure Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Ceased
Sirisha Jagadish Kumar Vaddi ceased to be Director.
Ceased
Abhishek Shriprkash Mishra ceased to be Director.
Ceased
Sachiv Kashinath Shukla ceased to be Director.
Appointed
Shivakant Mishra was appointed as Director.
Appointed
Virendra Dayashankar Mishra was appointed as Director.
Incorporation
30 Nov 2016
Vqure Pharmaceuticals Private Limited was registered on 30 Nov 2016 with Roc Mumbai & aged 9 years 10 months as per MCA records.
Frequently asked questions
Vqure Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 November 2016 (10+ years old) and is registered under CIN U51909MH2016PTC288054.
Vqure Pharmaceuticals has 2 current directors:
- Shivakant Mishra - Director
- Virendra Dayashankar Mishra - Director
The latest financial statements of Vqure Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2017 are in the company report.
No. Vqure Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Vqure Pharmaceuticals is U51909MH2016PTC288054. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vqure Pharmaceuticals has 10 court cases on record: 10 filed against it. 4 are pending.
Vqure Pharmaceuticals was incorporated on 30 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Vqure Pharmaceuticals by revenue are Nishant Distributors Private Limited, SVS Intermediates Private Limited, Jonas Pharmaceuticals Private Limited, Elemensis Lifesciences Private Limited, Tenfold Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Sirisha Jagadish Kumar Vaddi ceased to be Director on 24 Dec 2021. Abhishek Shriprkash Mishra ceased to be Director on 01 Aug 2018. Sachiv Kashinath Shukla ceased to be Director on 01 Aug 2018. Vqure Pharmaceuticals has 5 board changes on record in total.
Yes, Vqure Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0145635).
Vqure Pharmaceuticals can be reached through the website vqurepharma.com. Its registered office is in Thane, Maharashtra, India.